iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of Health and Human Services, through the National Institutes of Health's National Institute on Aging, intends to award a sole source contract to The Jackson Laboratory for the expansion, quality control, biobanking, and distribution of isogenic Alzheimer’s disease and related dementias induced pluripotent stem cell lines as part of the iPSC Neurodegenerative Disease Initiative (iNDI) Project. This contract will focus on providing up to 936 specific iPSC lines, including 486 FA13.1J female SNV lines and 450 lines across 25 high-priority SNV trios, adhering to iNDI protocols for quality and expansion. The Jackson Laboratory is uniquely qualified for this contract as it currently houses the existing distribution infrastructure and has demonstrated successful past performance in supporting NIH’s iNDI requirements. The contract is planned to be a firm-fixed-price agreement with a performance period starting September 1, 2026, for a base year and up to three option years, ending August 31, 2030. The primary place of performance will be the contractor’s facility in Bar Harbor, Maine. While this notice signals the intent for a sole source award, other capable sources may submit capability statements demonstrating their ability to meet the outlined requirements, including supply of the specific cell lines, adherence to quality protocols, product and web content creation, and public distribution via an established platform. Responses must be submitted electronically by June 23, 2026, and the Government reserves the right to consider all responses but is under no obligation to initiate a competitive procurement.
General Info
Agency
NAICS
Place of Performance
Bar Harbor, ME, 04609, USASet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
SPECIAL NOTICE
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Agency: Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Aging (NIA)
Office: Center for Alzheimer’s Disease and Related Dementias (CARD)
Notice Type: Special Notice
Notice Number: NIH-NOI-26-PCA-NIA-01205
Title: Notice of Intent to Sole Source – iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project
NAICS Code: 325414 – Biological Product (except Diagnostic) Manufacturing
PSC: 6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Description
This is a notice of intent to award a sole source contract and is not a request for competitive quotations, proposals, or bids. The National Institute on Aging (NIA), Center for Alzheimer’s Disease and Related Dementias (CARD), intends to negotiate and award a firm-fixed-price contract to:
The Jackson Laboratory
600 Main Street
Bar Harbor, ME 04609
UEI: XR6LMXNKDJJ1
for iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project.
The anticipated contract will provide for the expansion, quality control, curation, biobanking, and distribution of up to 936 isogenic Alzheimer’s disease and related dementias (ADRD) induced pluripotent stem cell (iPSC) lines in support of the iPSC Neurodegenerative Disease Initiative (iNDI). The requirement includes:
- FA13.1J female SNV lines totaling 486 iPSC lines;
- 25 high-priority SNV trios across six additional iPSC lines totaling 450 iPSC lines;
- expansion and quality control in accordance with current iNDI protocols;
- product and web content creation for each iPSC line; and
- public distribution of cell lines through an established contractor-hosted website/platform.
The statutory authority for this acquisition is 41 U.S.C. 1901, as implemented by FAR 13.501(a)(1)(ii), based on the circumstances described in FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
The Government’s market research included review of the prior sources sought notice posted on SAM.gov under Notice ID 75N95025Q00209-SBSS, review of prior NIH awards for similar iNDI requirements, and review of commercially available information regarding potential sources. Based on that market research, The Jackson Laboratory is the only known source capable of providing the specific iNDI FA13.1J iPSC cell lines and associated expansion, quality control, curation, and distribution services required for this acquisition. The Jackson Laboratory also maintains the existing iNDI distribution infrastructure and has successfully performed prior related iNDI requirements for NIH.
Period of Performance
- Base Year: September 1, 2026 – August 31, 2027
- Option Year 1: September 1, 2027 – August 31, 2028
- Option Year 2: September 1, 2028 – August 31, 2029
- Option Year 3: September 1, 2029 – August 31, 2030
Place of Performance
The principal place of performance is the contractor’s facility.
Responses
This notice is not a solicitation. However, any responsible source that believes it can satisfy the Government’s requirement may submit a capability statement for the Government’s consideration. Capability statements shall clearly demonstrate the ability to provide:
- the specific iNDI FA13.1J cell lines and associated iNDI lines required under this acquisition;
- expansion and quality control in accordance with current iNDI protocols;
- product and web content creation for each iPSC line;
- public distribution through an established contractor-hosted platform; and
- continuity sufficient to preserve comparability with existing iNDI resources and prior work.
Responses shall include, at a minimum:
- Company name
- UEI and CAGE Code, if applicable
- Business size and socioeconomic status
- Technical point of contact, including name, title, telephone number, and email address
- Narrative capability statement addressing the requirements above
- Relevant past performance information for similar efforts
Responses must be submitted electronically to the point(s) of contact below no later than June 23, 2026, 11:00 am EST. Responses received after the stated deadline may not be considered.
The Government will review all timely responses solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government will not be responsible for any costs incurred by respondents in preparing or submitting a response.
Point(s) of Contact
Primary Point of Contact: Linda Smith, Contracting Officer, linda.smith2@nih.gov
Secondary Point of Contact: Danielle Tines, Procurement Technician, danielle.tines@nih.gov